Melanoma treatment update at ASCO 2015 - European Medical Journal

Melanoma treatment update at ASCO 2015

Axel Hauschild, MD, of University of Schleswig-Holstein, Kiel, Germany, reviews the clinical trial data for new treatments in melanoma presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. He highlights trials on combined BRAF and MEK inhibition versus BRAF inhibition alone, and immunotherapy drug combinations.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now